3-amino-pyrazole derivatives useful against tuberculosis
AssigneeGlaxo Group Limited
InventorsRaquel Fernandez Menendez, Silvia Gonzalez Del Valle
Life of this patent
Estimating the term…
Loading patent…
AssigneeGlaxo Group Limited
InventorsRaquel Fernandez Menendez, Silvia Gonzalez Del Valle
Estimating the term…
A compound of Formula (I) or a pharmaceutically acceptable salt thereof: Wherein: Het is a 5 to 10-membered heteroaromatic ring; Either X is N and Y is CR5; or X is C and Y is S; Z is selected from N and CH; R1 is selected from H and C1-2alkyl; R2 is selected from H, C1-2alkyl, OH, —CH2OH and C1-2alkoxy; Each R3 is independently selected from OH, C1-3alkyl, F, Cl, Br, NH2, and C1-3alkoxy; R4 is selected from C1-3alkyl and haloC1-3 alkyl; R5 is selected from H, C1-3alkyl and haloC1-3alkyl; R6 and R7 are either i) each independently selected from H, C1-3alkyl and C1-3alkoxy; or ii) R6 and R7 together with the ring to which they are attached form a 9-membered bicylic ring; p is 0-3; and RA is selected from H and C1-3alkyl, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.
The compound 1-(4-ethylthiazol-2-yl)-1-[5-({1-[(2-methylthiazol-4-yl)methyl]-1H-pyrazol-3y}amino)-1,3,4-thiadiazol-2-yl]ethanol or a pharmaceutically acceptable salt thereof.
The compound 1-(4-ethylthiazol-2-yl)-1-[5-({1-[(2-methylthiazol-4-yl)methyl]-1H-pyrazol-3yl}amino)-1,3,4-thiadiazol-2-yl]ethanol.
The compound
Dependencies are inferred from the claim text.